Strides Pharma Science informs about press release

31 Oct 2025 Evaluate
Strides Pharma Science has enclosed Press Release (along with Earnings presentation) issued by the Company titled: ‘Strides Delivers a Robust Q2FY26 with Highest Ever Quarterly EPS Q2FY26 Operational PAT at ?1,403m and EPS at ?15.2, Grew 84% YoY’. The meeting commenced at 11:30 hrs IST and concluded at 12:50 hrs IST. The above information will also be available on website of the Company at www.strides.com

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

868.50 -14.25 (-1.61%)
15-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.25
Dr. Reddys Lab 1280.40
Cipla 1507.25
Zydus Lifesciences 921.25
Lupin 2090.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×